Intractable Nausea in a Patient with Metastatic Colorectal Cancer Following Insertion of a Colonic Stent  Mihaela Mates, MD, Deborah Dudgeon, MD, Lawrence C. Hookey, MD, David J. Hurlbut, MD, Paul Belliveau, MD, Christopher M. Booth, MD  Journal of Pain and Symptom Management  Volume 36, Issue 1, Pages e6-e10 (July 2008) DOI: 10.1016/j.jpainsymman.2008.02.003 Copyright © 2008 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 1 Colon segmental resection specimen opened with endoluminal stents in situ (a). The stented segment showed severe inflammatory disease with extensive ulceration and mural inflammation (b; original magnification 2×), mucosal acute and chronic inflammation with crypt distortion (c; original magnification 200×), and pseudopolyp formation (d; original magnification 2×). An invasive adenocarcinoma (T3 lesion), which was difficult to clearly identify on the mucosal aspect, was present at the distal portion of the stented segment (e; original magnification 2×; f, original magnification 50×; g, original magnification 250×). Journal of Pain and Symptom Management 2008 36, e6-e10DOI: (10.1016/j.jpainsymman.2008.02.003) Copyright © 2008 U.S. Cancer Pain Relief Committee Terms and Conditions